Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Celldex Therapeutics, Inc. (CLDX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Celldex Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 744218.
Total stock buying since 2015: $906,022.
Total stock sales since 2015: $11,528,594.
Total stock option exercises since 2015: $2,831,887.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 0 | $0 | 771 | $19,030 | 0 | $0 |
2024 | 11,500 | $308,430 | 60,000 | $2,112,705 | 63,706 | $427,676 |
2022 | 0 | $0 | 155,328 | $5,812,910 | 155,328 | $992,474 |
2021 | 430 | $19,900 | 50,501 | $2,131,578 | 80,552 | $664,479 |
2020 | 42,220 | $133,586 | 20,832 | $387,621 | 20,832 | $122,867 |
2018 | 56,500 | $28,984 | 0 | $0 | 0 | $0 |
2016 | 3,000 | $9,960 | 0 | $0 | 47,847 | $153,391 |
2015 | 25,800 | $405,162 | 50,000 | $1,064,750 | 60,000 | $471,000 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-08 | 0 | $0 | 771 | $19,030 | 0 | $0 |
2024-11 | 11,500 | $308,430 | 0 | $0 | 0 | $0 |
2024-06 | 0 | $0 | 60,000 | $2,112,705 | 39,540 | $285,145 |
2024-02 | 0 | $0 | 0 | $0 | 24,166 | $142,531 |
2022-08 | 0 | $0 | 155,328 | $5,812,910 | 155,328 | $992,474 |
2021-12 | 0 | $0 | 21,423 | $875,920 | 18,923 | $150,039 |
2021-11 | 0 | $0 | 26,340 | $1,131,764 | 26,711 | $149,611 |
2021-08 | 430 | $19,900 | 2,738 | $123,894 | 34,918 | $364,829 |
2020-12 | 0 | $0 | 20,832 | $387,621 | 20,832 | $122,867 |
2020-06 | 42,220 | $133,586 | 0 | $0 | 0 | $0 |
2018-08 | 40,000 | $19,200 | 0 | $0 | 0 | $0 |
2018-06 | 16,500 | $9,784 | 0 | $0 | 0 | $0 |
2016-09 | 3,000 | $9,960 | 0 | $0 | 10,000 | $28,000 |
2016-06 | 0 | $0 | 0 | $0 | 22,847 | $83,391 |
2016-03 | 0 | $0 | 0 | $0 | 15,000 | $42,000 |
2015-11 | 0 | $0 | 25,000 | $450,000 | 25,000 | $213,000 |
2015-09 | 0 | $0 | 0 | $0 | 10,000 | $45,000 |
2015-08 | 25,800 | $405,162 | 0 | $0 | 0 | $0 |
2015-06 | 0 | $0 | 25,000 | $614,750 | 25,000 | $213,000 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-08-13 | Jimenez Freddy A. (SVP & GENERAL COUNSEL) | Sale | 771 | 24.68 | 19,030 |
2024-11-11 | Marucci Anthony S (PRESIDENT & CEO) | Buy | 11,500 | 26.82 | 308,430 |
2024-06-11 | Young Diane C. (SVP, CHIEF MEDICAL OFFICER) | Option Ex | 15,000 | 2.71 | 40,650 |
2024-06-07 | Crowley Elizabeth (SR. VP & CPDO) | Sale | 15,000 | 35.06 | 525,870 |
2024-06-07 | Crowley Elizabeth (SR. VP & CPDO) | Option Ex | 15,000 | 9.70 | 145,470 |
2024-06-07 | Young Diane C. (SVP, CHIEF MEDICAL OFFICER) | Sale | 45,000 | 35.26 | 1,586,835 |
2024-06-05 | Jimenez Freddy A. (SVP & GENERAL COUNSEL) | Option Ex | 9,540 | 10.38 | 99,025 |
2024-02-13 | Jimenez Freddy A. (SVP & GENERAL COUNSEL) | Option Ex | 24,166 | 5.90 | 142,531 |
2022-08-15 | Wright Richard M. (SR. VP & CCO) | Sale | 15,328 | 37.71 | 578,049 |
2022-08-15 | Wright Richard M. (SR. VP & CCO) | Option Ex | 15,328 | 10.38 | 159,104 |
2022-08-15 | Marucci Anthony S (PRESIDENT & CEO) | Sale | 120,000 | 37.66 | 4,519,560 |
2022-08-15 | Marucci Anthony S (PRESIDENT & CEO) | Option Ex | 120,000 | 5.90 | 707,760 |
2022-08-12 | Martin Samuel Bates (SVP AND CFO) | Sale | 17,547 | 35.59 | 624,445 |
2022-08-12 | Martin Samuel Bates (SVP AND CFO) | Option Ex | 17,547 | 5.90 | 103,492 |
2022-08-11 | Martin Samuel Bates (SVP AND CFO) | Sale | 2,453 | 37.04 | 90,856 |
2022-08-11 | Martin Samuel Bates (SVP AND CFO) | Option Ex | 2,453 | 9.02 | 22,118 |
2021-12-23 | Martin Samuel Bates (SVP and CFO) | Sale | 9,500 | 42.00 | 399,000 |
2021-12-23 | Martin Samuel Bates (SVP and CFO) | Option Ex | 7,000 | 5.90 | 41,286 |
2021-12-08 | Heath-chiozzi Margo (SVP of Regulatory Affairs) | Sale | 600 | 40.00 | 24,000 |
2021-12-08 | Heath-chiozzi Margo (SVP of Regulatory Affairs) | Option Ex | 600 | 2.78 | 1,667 |
2021-12-08 | Cavanaugh Sarah (SVP of Corp Affairs & Admin.) | Sale | 7,323 | 40.00 | 292,920 |
2021-12-08 | Cavanaugh Sarah (SVP of Corp Affairs & Admin.) | Option Ex | 7,323 | 9.70 | 71,018 |
2021-12-08 | Crowley Elizabeth (Sr. VP &CPDO) | Sale | 4,000 | 40.00 | 160,000 |
2021-12-08 | Crowley Elizabeth (Sr. VP &CPDO) | Option Ex | 4,000 | 9.02 | 36,068 |
2021-11-15 | Martin Samuel Bates (SVP and CFO) | Sale | 9,500 | 43.10 | 409,421 |
2021-11-15 | Martin Samuel Bates (SVP and CFO) | Option Ex | 7,000 | 5.90 | 41,286 |
2021-11-12 | Young Diane C. (SVP, Chief Medical Officer) | Sale | 4,600 | 42.94 | 197,528 |
2021-11-12 | Young Diane C. (SVP, Chief Medical Officer) | Option Ex | 4,600 | 10.38 | 47,748 |
2021-11-01 | Heath-chiozzi Margo (SVP of Regulatory Affairs) | Sale | 600 | 41.71 | 25,026 |
2021-11-01 | Heath-chiozzi Margo (SVP of Regulatory Affairs) | Option Ex | 600 | 2.78 | 1,667 |
2021-11-01 | Cavanaugh Sarah (SVP of Corp Affairs & Admin.) | Sale | 7,323 | 42.93 | 314,383 |
2021-11-01 | Cavanaugh Sarah (SVP of Corp Affairs & Admin.) | Option Ex | 5,956 | 5.90 | 35,128 |
2021-11-01 | Crowley Elizabeth (Sr. VP &CPDO) | Sale | 4,317 | 42.95 | 185,406 |
2021-11-01 | Crowley Elizabeth (Sr. VP &CPDO) | Option Ex | 8,555 | 2.78 | 23,782 |
2021-08-11 | Jimenez Freddy A. (SVP & General Counsel) | Buy | 430 | 46.28 | 19,900 |
2021-08-11 | Heath-chiozzi Margo (SVP of Regulatory Affairs) | Option Ex | 10,000 | 9.02 | 90,170 |
2021-08-10 | Martin Samuel Bates (SVP and CFO) | Sale | 2,738 | 45.25 | 123,894 |
2021-08-10 | Martin Samuel Bates (SVP and CFO) | Option Ex | 21,381 | 5.90 | 126,105 |
2021-08-05 | Marucci Anthony S (President & CEO) | Option Ex | 3,537 | 42.00 | 148,554 |
2020-12-14 | Wright Richard M. (Sr. VP & CCO) | Sale | 20,832 | 18.61 | 387,621 |
2020-12-14 | Wright Richard M. (Sr. VP & CCO) | Option Ex | 20,832 | 5.90 | 122,867 |
2020-06-11 | Young Diane C. (SVP, Chief Medical Officer) | Buy | 2,115 | 4.73 | 10,003 |
2020-06-10 | Cavanaugh Sarah (SVP of Corp Affairs & Admin.) | Buy | 1,050 | 4.83 | 5,071 |
2020-06-09 | Heath-chiozzi Margo (SVP of Regulatory Affairs) | Buy | 1,000 | 3.00 | 3,005 |
2020-06-09 | Martin Samuel Bates (SVP and CFO) | Buy | 9,750 | 3.05 | 29,737 |
2020-06-09 | Marucci Anthony S (President & CEO) | Buy | 15,000 | 3.06 | 45,900 |
2020-06-09 | Keler Tibor (Executive VP & CSO) | Buy | 5,000 | 2.99 | 14,955 |
2020-06-09 | Marino James J | Buy | 8,305 | 3.00 | 24,915 |
2018-08-24 | Marino James J | Buy | 40,000 | .48 | 19,200 |
2018-06-15 | Keler Tibor (Executive VP & CSO) | Buy | 16,500 | .59 | 9,784 |
2016-09-02 | Keler Tibor (Executive VP & CSO) | Buy | 3,000 | 3.32 | 9,960 |
2016-09-02 | Catlin Avery W (Sr. VP & CFO) | Option Ex | 10,000 | 2.80 | 28,000 |
2016-06-03 | Catlin Avery W (Sr. VP & CFO) | Option Ex | 22,847 | 3.65 | 83,391 |
2016-03-09 | Catlin Avery W (Sr. VP & CFO) | Option Ex | 15,000 | 2.80 | 42,000 |
2015-11-23 | Catlin Avery W (Sr. VP & CFO) | Sale | 25,000 | 18.00 | 450,000 |
2015-11-23 | Catlin Avery W (Sr. VP & CFO) | Option Ex | 25,000 | 8.52 | 213,000 |
2015-09-11 | Catlin Avery W (Sr. VP & CFO) | Option Ex | 10,000 | 4.50 | 45,000 |
2015-08-25 | Ellberger Larry | Buy | 5,000 | 14.00 | 70,000 |
2015-08-20 | Ellberger Larry | Buy | 5,000 | 15.00 | 75,000 |
2015-08-18 | Ellberger Larry | Buy | 5,000 | 15.94 | 79,715 |
2015-08-13 | Marucci Anthony S (President and CEO) | Buy | 5,800 | 16.81 | 97,497 |
2015-08-13 | Ellberger Larry | Buy | 5,000 | 16.59 | 82,950 |
2015-06-15 | Catlin Avery W (Sr. VP & CFO) | Sale | 25,000 | 24.59 | 614,750 |
2015-06-15 | Catlin Avery W (Sr. VP & CFO) | Option Ex | 25,000 | 8.52 | 213,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of CLDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Celldex Therapeutics, Inc. (symbol CLDX, CIK number 744218) see the Securities and Exchange Commission (SEC) website.